The global preclinical CRO market is experiencing substantial growth, projected to reach a value of USD 5.72 billion in 2023 and is anticipated to expand at a CAGR of 8.7% from 2024 to 2030. This growth is primarily driven by increased R&D budgets allocated to drug development, leading to a surge in demand for preclinical CRO services. Additionally, the rising number of...